Expression Table for this CRE
| CNhs14498 | ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2 | 10325.8 |
| CNhs12229 | pituitary gland, adult, donor10252 | 272.1 |
| CNhs13841 | iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2 | 256.3 |
| CNhs12953 | Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15) | 198.4 |
| CNhs12662 | MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2 | 192.7 |
| CNhs14489 | ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2 | 175.3 |
| CNhs14496 | ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3 | 128.0 |
| CNhs12657 | MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2 | 118.2 |
| CNhs12663 | MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2 | 115.2 |
| CNhs12064 | Anulus Pulposus Cell, donor2 | 103.6 |
| CNhs12045 | Smooth Muscle Cells - Coronary Artery, donor3 | 103.3 |
| CNhs14492 | ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2 | 75.0 |
| CNhs12666 | MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2 | 74.4 |
| CNhs12664 | MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2 | 69.6 |
| CNhs12954 | Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2) | 68.8 |
| CNhs14495 | ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2 | 68.0 |
| CNhs12642 | Bronchial Epithelial Cell, donor7 | 66.4 |
| CNhs11725 | argyrophil small cell carcinoma cell line:TC-YIK | 62.6 |
| CNhs14573 | Myoblast differentiation to myotubes, day06, control donor2 | 62.5 |
| CNhs11371 | Adipocyte - subcutaneous, donor2 | 59.5 |
| CNhs11680 | lung, fetal, donor1 | 54.9 |
| CNhs14518 | ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3 | 54.5 |
| CNhs12658 | MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2 | 52.2 |
| CNhs14501 | ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2 | 50.5 |
| CNhs12659 | MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2 | 50.1 |
| CNhs12656 | MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2 | 47.3 |
| CNhs14490 | ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3 | 45.5 |
| CNhs11723 | leiomyoma cell line:15242A | 41.3 |
| CNhs12654 | MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2 | 40.0 |
| CNhs14497 | ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1 | 39.1 |
| CNhs12655 | MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2 | 38.7 |
| CNhs11718 | mesenchymal stem cell line:Hu5/E18 | 38.7 |
| CNhs12079 | Pericytes, donor2 | 38.3 |
| CNhs12660 | MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2 | 37.5 |
| CNhs14493 | ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3 | 36.2 |
| CNhs12060 | Skeletal Muscle Cells, donor6 | 35.9 |
| CNhs13434 | mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1 | 34.2 |
| CNhs14488 | ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1 | 33.8 |
| CNhs14491 | ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1 | 31.8 |
| CNhs12075 | Hepatic Sinusoidal Endothelial Cells, donor1 | 31.8 |
| CNhs12052 | Fibroblast - Dermal, donor4 | 29.0 |
| CNhs12684 | K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2 | 28.2 |
| CNhs14417 | 293SLAM rinderpest infection, 24hr, biol_rep2 | 27.9 |
| CNhs11715 | Hodgkin's lymphoma cell line:HD-Mar2 | 27.8 |
| CNhs11717 | oral squamous cell carcinoma cell line:HSC-3 | 26.9 |
| CNhs12061 | Fibroblast - Cardiac, donor6 | 26.3 |
| CNhs11714 | chronic lymphocytic leukemia (T-CLL) cell line:SKW-3 | 23.1 |
| CNhs12665 | MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2 | 22.9 |
| CNhs13328 | Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3) | 20.1 |
| CNhs11677 | salivary gland, adult, pool1 | 20.0 |